| Symbol |
Name |
|
A2M
|
alpha-2-macroglobulin
|
|
ABCA1
|
ATP-binding cassette, sub-family A (ABC1), member 1
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCC11
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 11
|
|
ABCC2
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 2
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ABO
|
ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)
|
|
ACADM
|
acyl-CoA dehydrogenase, C-4 to C-12 straight chain
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACKR1
|
atypical chemokine receptor 1 (Duffy blood group)
|
|
ACP1
|
acid phosphatase 1, soluble
|
|
ACTN3
|
actinin, alpha 3 (gene/pseudogene)
|
|
ACVR2A
|
activin A receptor, type IIA
|
|
ACVRL1
|
activin A receptor type II-like 1
|
|
ADCYAP1
|
adenylate cyclase activating polypeptide 1 (pituitary)
|
|
ADD1
|
adducin 1 (alpha)
|
|
ADH1B
|
alcohol dehydrogenase 1B (class I), beta polypeptide
|
|
ADH1C
|
alcohol dehydrogenase 1C (class I), gamma polypeptide
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADRA2C
|
adrenoceptor alpha 2C
|
|
ADRB1
|
adrenoceptor beta 1
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
ADRB3
|
adrenoceptor beta 3
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AGXT
|
alanine-glyoxylate aminotransferase
|
|
AHI1
|
Abelson helper integration site 1
|
|
AHR
|
aryl hydrocarbon receptor
|
|
ALAD
|
aminolevulinate dehydratase
|
|
ALDH2
|
aldehyde dehydrogenase 2 family (mitochondrial)
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ALPL
|
alkaline phosphatase, liver/bone/kidney
|
|
AMPD1
|
adenosine monophosphate deaminase 1
|
|
ANGPT2
|
angiopoietin 2
|
|
ANK1
|
ankyrin 1, erythrocytic
|
|
ANKK1
|
ankyrin repeat and kinase domain containing 1
|
|
ANXA10
|
annexin A10
|
|
APC
|
adenomatous polyposis coli
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
|
APOA1
|
apolipoprotein A-I
|
|
APOA5
|
apolipoprotein A-V
|
|
APOE
|
apolipoprotein E
|
|
ARNT
|
aryl hydrocarbon receptor nuclear translocator
|
|
ARTN
|
artemin
|
|
AS3MT
|
arsenite methyltransferase
|
|
ATP7B
|
ATPase, Cu++ transporting, beta polypeptide
|
|
ATXN1
|
ataxin 1
|
|
ATXN2
|
ataxin 2
|
|
ATXN3
|
ataxin 3
|
|
B3GALNT1
|
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)
|
|
BAP1
|
BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)
|
|
BBS1
|
Bardet-Biedl syndrome 1
|
|
BCHE
|
butyrylcholinesterase
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BCR
|
breakpoint cluster region
|
|
BDKRB2
|
bradykinin receptor B2
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BRD2
|
bromodomain containing 2
|
|
BTD
|
biotinidase
|
|
BTN2A1
|
butyrophilin, subfamily 2, member A1
|
|
C3
|
complement component 3
|
|
CA4
|
carbonic anhydrase IV
|
|
CACNA1C
|
calcium channel, voltage-dependent, L type, alpha 1C subunit
|
|
CALCA
|
calcitonin-related polypeptide alpha
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CAT
|
catalase
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL3
|
chemokine (C-C motif) ligand 3
|
|
CCL4
|
chemokine (C-C motif) ligand 4
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CD14
|
CD14 molecule
|
|
CD209
|
CD209 molecule
|
|
CD276
|
CD276 molecule
|
|
CD28
|
CD28 molecule
|
|
CD4
|
CD4 molecule
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD80
|
CD80 molecule
|
|
CD83
|
CD83 molecule
|
|
CD86
|
CD86 molecule
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH13
|
cadherin 13
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CFH
|
complement factor H
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHIT1
|
chitinase 1 (chitotriosidase)
|
|
CHMP2B
|
charged multivesicular body protein 2B
|
|
CIITA
|
class II, major histocompatibility complex, transactivator
|
|
CLDN14
|
claudin 14
|
|
CLOCK
|
clock circadian regulator
|
|
COL17A1
|
collagen, type XVII, alpha 1
|
|
COL2A1
|
collagen, type II, alpha 1
|
|
COL4A3BP
|
collagen, type IV, alpha 3 (Goodpasture antigen) binding protein
|
|
COL6A4P1
|
collagen, type VI, alpha 4 pseudogene 1
|
|
COL9A2
|
collagen, type IX, alpha 2
|
|
COL9A3
|
collagen, type IX, alpha 3
|
|
COMT
|
catechol-O-methyltransferase
|
|
CR1
|
complement component (3b/4b) receptor 1 (Knops blood group)
|
|
CR2
|
complement component (3d/Epstein Barr virus) receptor 2
|
|
CRB1
|
crumbs family member 1, photoreceptor morphogenesis associated
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CRLF2
|
cytokine receptor-like factor 2
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CTDSPL
|
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase-like
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTRC
|
chymotrypsin C (caldecrin)
|
|
CTSD
|
cathepsin D
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL5
|
chemokine (C-X-C motif) ligand 5
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CYP11B2
|
cytochrome P450, family 11, subfamily B, polypeptide 2
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
|
CYP21A2
|
cytochrome P450, family 21, subfamily A, polypeptide 2
|
|
CYP27B1
|
cytochrome P450, family 27, subfamily B, polypeptide 1
|
|
CYP2A13
|
cytochrome P450, family 2, subfamily A, polypeptide 13
|
|
CYP2A6
|
cytochrome P450, family 2, subfamily A, polypeptide 6
|
|
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2C8
|
cytochrome P450, family 2, subfamily C, polypeptide 8
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
|
CYP2R1
|
cytochrome P450, family 2, subfamily R, polypeptide 1
|
|
CYP3A
|
cytochrome P450, family 3, subfamily A
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYP3A43
|
cytochrome P450, family 3, subfamily A, polypeptide 43
|
|
CYP3A5
|
cytochrome P450, family 3, subfamily A, polypeptide 5
|
|
CYP46A1
|
cytochrome P450, family 46, subfamily A, polypeptide 1
|
|
CYP7A1
|
cytochrome P450, family 7, subfamily A, polypeptide 1
|
|
DAPK1
|
death-associated protein kinase 1
|
|
DBH
|
dopamine beta-hydroxylase (dopamine beta-monooxygenase)
|
|
DEFB1
|
defensin, beta 1
|
|
DHFR
|
dihydrofolate reductase
|
|
DMPK
|
dystrophia myotonica-protein kinase
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
DRD2
|
dopamine receptor D2
|
|
DRD3
|
dopamine receptor D3
|
|
DRD4
|
dopamine receptor D4
|
|
DST
|
dystonin
|
|
DUOX1
|
dual oxidase 1
|
|
DUOX2
|
dual oxidase 2
|
|
DYSF
|
dysferlin
|
|
EDN1
|
endothelin 1
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
ENG
|
endoglin
|
|
EPHX1
|
epoxide hydrolase 1, microsomal (xenobiotic)
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ERCC4
|
excision repair cross-complementation group 4
|
|
ESD
|
esterase D
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
EXO1
|
exonuclease 1
|
|
F12
|
coagulation factor XII (Hageman factor)
|
|
F2
|
coagulation factor II (thrombin)
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FBN1
|
fibrillin 1
|
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase
|
|
FCER1A
|
Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
|
FCGR3B
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b)
|
|
FCN2
|
ficolin (collagen/fibrinogen domain containing lectin) 2
|
|
FCRL3
|
Fc receptor-like 3
|
|
FGA
|
fibrinogen alpha chain
|
|
FGB
|
fibrinogen beta chain
|
|
FGD1
|
FYVE, RhoGEF and PH domain containing 1
|
|
FHIT
|
fragile histidine triad
|
|
FLG
|
filaggrin
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FMO3
|
flavin containing monooxygenase 3
|
|
FOXP3
|
forkhead box P3
|
|
FPGS
|
folylpolyglutamate synthase
|
|
FTO
|
fat mass and obesity associated
|
|
FUT2
|
fucosyltransferase 2 (secretor status included)
|
|
FUT3
|
fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group)
|
|
FXN
|
frataxin
|
|
G6PD
|
glucose-6-phosphate dehydrogenase
|
|
GABRB3
|
gamma-aminobutyric acid (GABA) A receptor, beta 3
|
|
GABRR1
|
gamma-aminobutyric acid (GABA) A receptor, rho 1
|
|
GABRR2
|
gamma-aminobutyric acid (GABA) A receptor, rho 2
|
|
GABRR3
|
gamma-aminobutyric acid (GABA) A receptor, rho 3 (gene/pseudogene)
|
|
GALNT11
|
polypeptide N-acetylgalactosaminyltransferase 11
|
|
GALT
|
galactose-1-phosphate uridylyltransferase
|
|
GAST
|
gastrin
|
|
GBA
|
glucosidase, beta, acid
|
|
GC
|
group-specific component (vitamin D binding protein)
|
|
GCK
|
glucokinase (hexokinase 4)
|
|
GDF5
|
growth differentiation factor 5
|
|
GDNF
|
glial cell derived neurotrophic factor
|
|
GHR
|
growth hormone receptor
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GJB1
|
gap junction protein, beta 1, 32kDa
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GJB6
|
gap junction protein, beta 6, 30kDa
|
|
GJC2
|
gap junction protein, gamma 2, 47kDa
|
|
GLA
|
galactosidase, alpha
|
|
GLO1
|
glyoxalase I
|
|
GNAS
|
GNAS complex locus
|
|
GNB3
|
guanine nucleotide binding protein (G protein), beta polypeptide 3
|
|
GP1BA
|
glycoprotein Ib (platelet), alpha polypeptide
|
|
GPX1
|
glutathione peroxidase 1
|
|
GRN
|
granulin
|
|
GSTA1
|
glutathione S-transferase alpha 1
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTM3
|
glutathione S-transferase mu 3 (brain)
|
|
GSTO1
|
glutathione S-transferase omega 1
|
|
GSTO2
|
glutathione S-transferase omega 2
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
GSTZ1
|
glutathione S-transferase zeta 1
|
|
H19
|
H19, imprinted maternally expressed transcript (non-protein coding)
|
|
HBA1
|
hemoglobin, alpha 1
|
|
HBB
|
hemoglobin, beta
|
|
HFE
|
hemochromatosis
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DPA1
|
major histocompatibility complex, class II, DP alpha 1
|
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-DRB4
|
major histocompatibility complex, class II, DR beta 4
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
|
HMHA1
|
histocompatibility (minor) HA-1
|
|
HNF1A
|
HNF1 homeobox A
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HOXD11
|
homeobox D11
|
|
HOXD12
|
homeobox D12
|
|
HOXD13
|
homeobox D13
|
|
HP
|
haptoglobin
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSD17B1
|
hydroxysteroid (17-beta) dehydrogenase 1
|
|
HSD17B2
|
hydroxysteroid (17-beta) dehydrogenase 2
|
|
HSPA1A
|
heat shock 70kDa protein 1A
|
|
HSPA1B
|
heat shock 70kDa protein 1B
|
|
HSPA1L
|
heat shock 70kDa protein 1-like
|
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
|
|
HSPD1
|
heat shock 60kDa protein 1 (chaperonin)
|
|
HTR1A
|
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
HTR2C
|
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ICOS
|
inducible T-cell co-stimulator
|
|
IDE
|
insulin-degrading enzyme
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IFNA1
|
interferon, alpha 1
|
|
IFNG
|
interferon, gamma
|
|
IFNL3
|
interferon, lambda 3
|
|
IFNL4
|
interferon, lambda 4 (gene/pseudogene)
|
|
IGF2
|
insulin-like growth factor 2
|
|
IL10
|
interleukin 10
|
|
IL11
|
interleukin 11
|
|
IL12B
|
interleukin 12B
|
|
IL12RB2
|
interleukin 12 receptor, beta 2
|
|
IL15
|
interleukin 15
|
|
IL15RA
|
interleukin 15 receptor, alpha
|
|
IL16
|
interleukin 16
|
|
IL17A
|
interleukin 17A
|
|
IL17F
|
interleukin 17F
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL1R1
|
interleukin 1 receptor, type I
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL22
|
interleukin 22
|
|
IL27
|
interleukin 27
|
|
IL2RB
|
interleukin 2 receptor, beta
|
|
IL3
|
interleukin 3
|
|
IL4
|
interleukin 4
|
|
IL4R
|
interleukin 4 receptor
|
|
IL6
|
interleukin 6
|
|
IL7R
|
interleukin 7 receptor
|
|
IMPDH2
|
IMP (inosine 5'-monophosphate) dehydrogenase 2
|
|
IRF1
|
interferon regulatory factor 1
|
|
IRF6
|
interferon regulatory factor 6
|
|
IRS2
|
insulin receptor substrate 2
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
|
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
|
ITGAX
|
integrin, alpha X (complement component 3 receptor 4 subunit)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITPA
|
inosine triphosphatase (nucleoside triphosphate pyrophosphatase)
|
|
JAK1
|
Janus kinase 1
|
|
JAK2
|
Janus kinase 2
|
|
KCNE3
|
potassium channel, voltage gated subfamily E regulatory beta subunit 3
|
|
KCNJ5
|
potassium channel, inwardly rectifying subfamily J, member 5
|
|
KCNJ9
|
potassium channel, inwardly rectifying subfamily J, member 9
|
|
KDM5C
|
lysine (K)-specific demethylase 5C
|
|
KIR2DL4
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4
|
|
KIR2DL5A
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 5A
|
|
KIR2DS1
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 1
|
|
KIR2DS2
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2
|
|
KIR2DS3
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 3
|
|
KIR3DL1
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1
|
|
KIR3DL2
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2
|
|
KIR3DL3
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 3
|
|
KIR3DS1
|
killer cell immunoglobulin-like receptor, three domains, short cytoplasmic tail, 1
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KLK1
|
kallikrein 1
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
LCT
|
lactase
|
|
LEP
|
leptin
|
|
LEPR
|
leptin receptor
|
|
LINGO1
|
leucine rich repeat and Ig domain containing 1
|
|
LIPA
|
lipase A, lysosomal acid, cholesterol esterase
|
|
LOX
|
lysyl oxidase
|
|
LPL
|
lipoprotein lipase
|
|
LRP1
|
low density lipoprotein receptor-related protein 1
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
LY6G6D
|
lymphocyte antigen 6 complex, locus G6D
|
|
MAOA
|
monoamine oxidase A
|
|
MAOB
|
monoamine oxidase B
|
|
MAP1LC3A
|
microtubule-associated protein 1 light chain 3 alpha
|
|
MAP4K3
|
mitogen-activated protein kinase kinase kinase kinase 3
|
|
MAPT
|
microtubule-associated protein tau
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MC1R
|
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)
|
|
MC4R
|
melanocortin 4 receptor
|
|
MCM6
|
minichromosome maintenance complex component 6
|
|
MCPH1
|
microcephalin 1
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MEF2A
|
myocyte enhancer factor 2A
|
|
MEF2C
|
myocyte enhancer factor 2C
|
|
MEFV
|
Mediterranean fever
|
|
MEN1
|
multiple endocrine neoplasia I
|
|
MFSD2A
|
major facilitator superfamily domain containing 2A
|
|
MGP
|
matrix Gla protein
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MICB
|
MHC class I polypeptide-related sequence B
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR137
|
microRNA 137
|
|
MIR143
|
microRNA 143
|
|
MLH1
|
mutL homolog 1
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MMP8
|
matrix metallopeptidase 8
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MPL
|
MPL proto-oncogene, thrombopoietin receptor
|
|
MPO
|
myeloperoxidase
|
|
MPZ
|
myelin protein zero
|
|
MTHFD1
|
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1, methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthetase
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTR
|
5-methyltetrahydrofolate-homocysteine methyltransferase
|
|
MTRR
|
5-methyltetrahydrofolate-homocysteine methyltransferase reductase
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC6
|
mucin 6, oligomeric mucus/gel-forming
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYD88
|
myeloid differentiation primary response 88
|
|
MYH9
|
myosin, heavy chain 9, non-muscle
|
|
MYO1A
|
myosin IA
|
|
MYO1G
|
myosin IG
|
|
NAT1
|
N-acetyltransferase 1 (arylamine N-acetyltransferase)
|
|
NAT2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|
NBN
|
nibrin
|
|
NEFM
|
neurofilament, medium polypeptide
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NME8
|
NME/NM23 family member 8
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH4
|
notch 4
|
|
NOX4
|
NADPH oxidase 4
|
|
NPHS2
|
nephrosis 2, idiopathic, steroid-resistant (podocin)
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPTX2
|
neuronal pentraxin II
|
|
NPY
|
neuropeptide Y
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1
|
|
NRG1
|
neuregulin 1
|
|
NRTN
|
neurturin
|
|
NTNG1
|
netrin G1
|
|
NYX
|
nyctalopin
|
|
OCA2
|
oculocutaneous albinism II
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
OPN4
|
opsin 4
|
|
P2RY12
|
purinergic receptor P2Y, G-protein coupled, 12
|
|
PAH
|
phenylalanine hydroxylase
|
|
PARK16
|
Parkinson disease 16 (susceptibility)
|
|
PARK7
|
parkinson protein 7
|
|
PARL
|
presenilin associated, rhomboid-like
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PBRM1
|
polybromo 1
|
|
PCLO
|
piccolo presynaptic cytomatrix protein
|
|
PDCD1
|
programmed cell death 1
|
|
PDE3A
|
phosphodiesterase 3A, cGMP-inhibited
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
|
PER3
|
period circadian clock 3
|
|
PGM1
|
phosphoglucomutase 1
|
|
PGR
|
progesterone receptor
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PITX3
|
paired-like homeodomain 3
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PML
|
promyelocytic leukemia
|
|
PMP22
|
peripheral myelin protein 22
|
|
POLB
|
polymerase (DNA directed), beta
|
|
POLG
|
polymerase (DNA directed), gamma
|
|
POLH
|
polymerase (DNA directed), eta
|
|
PON1
|
paraoxonase 1
|
|
PON2
|
paraoxonase 2
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PRF1
|
perforin 1 (pore forming protein)
|
|
PRNP
|
prion protein
|
|
PROZ
|
protein Z, vitamin K-dependent plasma glycoprotein
|
|
PRPF31
|
pre-mRNA processing factor 31
|
|
PRPH2
|
peripherin 2 (retinal degeneration, slow)
|
|
PRSS1
|
protease, serine, 1 (trypsin 1)
|
|
PSMB8
|
proteasome (prosome, macropain) subunit, beta type, 8
|
|
PSMB9
|
proteasome (prosome, macropain) subunit, beta type, 9
|
|
PSPN
|
persephin
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGDR2
|
prostaglandin D2 receptor 2
|
|
PTGIR
|
prostaglandin I2 (prostacyclin) receptor (IP)
|
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTH1R
|
parathyroid hormone 1 receptor
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
|
RAD51
|
RAD51 recombinase
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RB1
|
retinoblastoma 1
|
|
RET
|
ret proto-oncogene
|
|
REV1
|
REV1, polymerase (DNA directed)
|
|
RFC1
|
replication factor C (activator 1) 1, 145kDa
|
|
RGS2
|
regulator of G-protein signaling 2
|
|
RHCE
|
Rh blood group, CcEe antigens
|
|
RHD
|
Rh blood group, D antigen
|
|
RHO
|
rhodopsin
|
|
RPSA
|
ribosomal protein SA
|
|
RRP9
|
ribosomal RNA processing 9, small subunit (SSU) processome component, homolog (yeast)
|
|
RTN4
|
reticulon 4
|
|
RUNX1
|
runt-related transcription factor 1
|
|
SCGB3A1
|
secretoglobin, family 3A, member 1
|
|
SCN2A
|
sodium channel, voltage gated, type II alpha subunit
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SCNN1A
|
sodium channel, non voltage gated 1 alpha subunit
|
|
SDHB
|
succinate dehydrogenase complex, subunit B, iron sulfur (Ip)
|
|
SELE
|
selectin E
|
|
SELP
|
selectin P (granule membrane protein 140kDa, antigen CD62)
|
|
SEMG1
|
semenogelin I
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SERPINA12
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 12
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SETD2
|
SET domain containing 2
|
|
SF3B1
|
splicing factor 3b, subunit 1, 155kDa
|
|
SFTPB
|
surfactant protein B
|
|
SFTPC
|
surfactant protein C
|
|
SLC11A1
|
solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1
|
|
SLC19A1
|
solute carrier family 19 (folate transporter), member 1
|
|
SLC25A12
|
solute carrier family 25 (aspartate/glutamate carrier), member 12
|
|
SLC26A4
|
solute carrier family 26 (anion exchanger), member 4
|
|
SLC30A8
|
solute carrier family 30 (zinc transporter), member 8
|
|
SLC40A1
|
solute carrier family 40 (iron-regulated transporter), member 1
|
|
SLC44A2
|
solute carrier family 44 (choline transporter), member 2
|
|
SLC4A1
|
solute carrier family 4 (anion exchanger), member 1 (Diego blood group)
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLCO1A2
|
solute carrier organic anion transporter family, member 1A2
|
|
SLCO1B1
|
solute carrier organic anion transporter family, member 1B1
|
|
SLCO1B3
|
solute carrier organic anion transporter family, member 1B3
|
|
SLCO2B1
|
solute carrier organic anion transporter family, member 2B1
|
|
SLIT2
|
slit homolog 2 (Drosophila)
|
|
SMN1
|
survival of motor neuron 1, telomeric
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SOD3
|
superoxide dismutase 3, extracellular
|
|
SORL1
|
sortilin-related receptor, L(DLR class) A repeats containing
|
|
SOX18
|
SRY (sex determining region Y)-box 18
|
|
SPINK1
|
serine peptidase inhibitor, Kazal type 1
|
|
SRD5A2
|
steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)
|
|
SREBF1
|
sterol regulatory element binding transcription factor 1
|
|
STX1A
|
syntaxin 1A (brain)
|
|
SULT1A1
|
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1
|
|
SULT1A2
|
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2
|
|
SYN1
|
synapsin I
|
|
TAF1
|
TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 250kDa
|
|
TAP1
|
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)
|
|
TAP2
|
transporter 2, ATP-binding cassette, sub-family B (MDR/TAP)
|
|
TAS1R1
|
taste receptor, type 1, member 1
|
|
TAS1R3
|
taste receptor, type 1, member 3
|
|
TAS2R38
|
taste receptor, type 2, member 38
|
|
TAX1BP1
|
Tax1 (human T-cell leukemia virus type I) binding protein 1
|
|
TBP
|
TATA box binding protein
|
|
TBX21
|
T-box 21
|
|
TBXA2R
|
thromboxane A2 receptor
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TERT
|
telomerase reverse transcriptase
|
|
TET1
|
tet methylcytosine dioxygenase 1
|
|
TF
|
transferrin
|
|
TFAM
|
transcription factor A, mitochondrial
|
|
TFAP2B
|
transcription factor AP-2 beta (activating enhancer binding protein 2 beta)
|
|
TFRC
|
transferrin receptor
|
|
TG
|
thyroglobulin
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB2
|
transforming growth factor, beta 2
|
|
TGFB3
|
transforming growth factor, beta 3
|
|
TIRAP
|
toll-interleukin 1 receptor (TIR) domain containing adaptor protein
|
|
TK1
|
thymidine kinase 1, soluble
|
|
TLR2
|
toll-like receptor 2
|
|
TLR4
|
toll-like receptor 4
|
|
TLR5
|
toll-like receptor 5
|
|
TLR9
|
toll-like receptor 9
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
|
TNFRSF11A
|
tumor necrosis factor receptor superfamily, member 11a, NFKB activator
|
|
TNFRSF9
|
tumor necrosis factor receptor superfamily, member 9
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TNFSF4
|
tumor necrosis factor (ligand) superfamily, member 4
|
|
TOMM40
|
translocase of outer mitochondrial membrane 40 homolog (yeast)
|
|
TP53
|
tumor protein p53
|
|
TP73
|
tumor protein p73
|
|
TPD52
|
tumor protein D52
|
|
TPH1
|
tryptophan hydroxylase 1
|
|
TPH2
|
tryptophan hydroxylase 2
|
|
TPMT
|
thiopurine S-methyltransferase
|
|
TRB
|
T cell receptor beta locus
|
|
TRIT1
|
tRNA isopentenyltransferase 1
|
|
TSHR
|
thyroid stimulating hormone receptor
|
|
TUBB
|
tubulin, beta class I
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
TYMS
|
thymidylate synthetase
|
|
UCP2
|
uncoupling protein 2 (mitochondrial, proton carrier)
|
|
UCP3
|
uncoupling protein 3 (mitochondrial, proton carrier)
|
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A1
|
|
UGT1A4
|
UDP glucuronosyltransferase 1 family, polypeptide A4
|
|
UGT1A7
|
UDP glucuronosyltransferase 1 family, polypeptide A7
|
|
UNG
|
uracil-DNA glycosylase
|
|
USH2A
|
Usher syndrome 2A (autosomal recessive, mild)
|
|
USP26
|
ubiquitin specific peptidase 26
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VKORC1
|
vitamin K epoxide reductase complex, subunit 1
|
|
WFS1
|
Wolfram syndrome 1 (wolframin)
|
|
WIF1
|
WNT inhibitory factor 1
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
XRCC3
|
X-ray repair complementing defective repair in Chinese hamster cells 3
|
|
XRCC4
|
X-ray repair complementing defective repair in Chinese hamster cells 4
|
